Skip to main content
Erschienen in: European Radiology 8/2012

01.08.2012 | Oncology

Assessment of the metabolic flow phenotype of primary colorectal cancer: correlations with microvessel density are influenced by the histological scoring method

verfasst von: Vicky Goh, Manuel Rodriguez-Justo, Alec Engledow, Manu Shastry, Raymondo Endozo, Jacqui Peck, Marie Meagher, Stuart A. Taylor, Steve Halligan, Ashley M. Groves

Erschienen in: European Radiology | Ausgabe 8/2012

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To investigate how the histological scoring of microvessel density affects correlations between integrated 18F-FDG-PET/perfusion CT parameters and CD105 microvessel density.

Methods

A total of 53 patients were enrolled from 2007 to 2010. Integrated 18F-FDG-PET/perfusion CT was successful in 45 patients, 35 of whom underwent surgery without intervening treatment. Tumour SUVmax, SUVmean and regional blood flow (BF) were derived. Immunohistochemical staining for CD105 expression and analysis were performed for two hot spots, four hot spots and the Chalkley method. Correlations between metabolic flow parameters and CD105 expression were assessed using Spearman’s rank correlation.

Results

Mean (SD) for tumour size was 38.5 (20.5) mm, for SUVmax, SUVmean and BF it was 19.1 (4.5), 11.6 (2.5) and 85.4 (40.3) mL/min/100 g tissue, and for CD105 microvessel density it was 71.4 (23.6), 66.8 (22.9) and 6.18 (2.07) for two hot spots, four hot spots and the Chalkley method, respectively. Positive correlation between BF and CD105 expression was modest but higher for Chalkley than for four hot spots analysis (r = 0.38, P = 0.03; r = 0.33, P = 0.05, respectively). There were no significant correlations between metabolic parameters (SUVmax or SUVmean) and CD105 expression (r = 0.08–0.22, P = 0.21–0.63).

Conclusions

The histological analysis method affects correlations between tumour CD105 expression and BF but not SUVmax or SUVmean.

Key Points

• FDG-PET/perfusion CT offers new surrogate biomarkers of angiogenesis.
• Microvessel density scoring influences histopathological correlations with CT blood flow.
• Highest correlations were found with the Chalkley analysis method.
• Correlations between SUV and CD105 are not affected by the scoring method.
Literatur
1.
Zurück zum Zitat Hurwitz H, Fehrenbacher L, Novotny W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335–2342PubMedCrossRef Hurwitz H, Fehrenbacher L, Novotny W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335–2342PubMedCrossRef
2.
Zurück zum Zitat Peeters M, Price TJ, Cervantes A et al (2010) Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second line treatment in patients with metastatic colorectal cancer. J Clin Oncol 28:4706–4713PubMedCrossRef Peeters M, Price TJ, Cervantes A et al (2010) Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second line treatment in patients with metastatic colorectal cancer. J Clin Oncol 28:4706–4713PubMedCrossRef
3.
Zurück zum Zitat Van Cutsem E, Köhne CH, Hitre E et al (2009) Cetuximab and chemotherapy as first line treatment for metastatic colorectal cancer. N Engl J Med 360:1408–1417PubMedCrossRef Van Cutsem E, Köhne CH, Hitre E et al (2009) Cetuximab and chemotherapy as first line treatment for metastatic colorectal cancer. N Engl J Med 360:1408–1417PubMedCrossRef
4.
Zurück zum Zitat Jonker DJ, O'Callaghan CJ, Karapetis CS et al (2007) Cetuximab for the treatment of colorectal cancer. N Engl J Med 357:2040–2048PubMedCrossRef Jonker DJ, O'Callaghan CJ, Karapetis CS et al (2007) Cetuximab for the treatment of colorectal cancer. N Engl J Med 357:2040–2048PubMedCrossRef
5.
Zurück zum Zitat Kaira K, Okumura T, Ohde Y et al (2011) Correlation between 18F-FDG uptake on PET and molecular biology in metastatic pulmonary tumors. J Nucl Med 52:705–711PubMedCrossRef Kaira K, Okumura T, Ohde Y et al (2011) Correlation between 18F-FDG uptake on PET and molecular biology in metastatic pulmonary tumors. J Nucl Med 52:705–711PubMedCrossRef
6.
Zurück zum Zitat Kaira K, Endo M, Abe M et al (2011) Biologic correlates of 18F-FDG uptake on PET in pulmonary pleomorphic carcinoma. Lung Cancer 71:144–150PubMedCrossRef Kaira K, Endo M, Abe M et al (2011) Biologic correlates of 18F-FDG uptake on PET in pulmonary pleomorphic carcinoma. Lung Cancer 71:144–150PubMedCrossRef
7.
Zurück zum Zitat Kaira K, Endo M, Abe M et al (2010) Biologic correlation of 2-[18F]-fluoro-2-deoxy-d-glucose uptake on positron emission tomography in thymic epithelial tumors. J Clin Oncol 28:3746–3753PubMedCrossRef Kaira K, Endo M, Abe M et al (2010) Biologic correlation of 2-[18F]-fluoro-2-deoxy-d-glucose uptake on positron emission tomography in thymic epithelial tumors. J Clin Oncol 28:3746–3753PubMedCrossRef
8.
Zurück zum Zitat Groves AM, Shastry M, Rodriguez-Justo M et al (2011) 18F-FDG PET and biomarkers for tumour angiogenesis in early breast cancer. Eur J Nucl Med Mol Imaging 38:46–52PubMedCrossRef Groves AM, Shastry M, Rodriguez-Justo M et al (2011) 18F-FDG PET and biomarkers for tumour angiogenesis in early breast cancer. Eur J Nucl Med Mol Imaging 38:46–52PubMedCrossRef
9.
Zurück zum Zitat Li Y, Yang ZG, Chen TW et al (2008) Peripheral lung carcinoma: correlation of angiogenesis and first-pass perfusion parameters of 64-detector row CT. Lung Cancer 61:44–53PubMedCrossRef Li Y, Yang ZG, Chen TW et al (2008) Peripheral lung carcinoma: correlation of angiogenesis and first-pass perfusion parameters of 64-detector row CT. Lung Cancer 61:44–53PubMedCrossRef
10.
Zurück zum Zitat Goh V, Halligan S, Daley F et al (2008) Colorectal tumor vascularity: quantitative assessment with multidetector CT—do tumor perfusion measurements reflect angiogenesis? Radiology 249:510–517PubMedCrossRef Goh V, Halligan S, Daley F et al (2008) Colorectal tumor vascularity: quantitative assessment with multidetector CT—do tumor perfusion measurements reflect angiogenesis? Radiology 249:510–517PubMedCrossRef
11.
Zurück zum Zitat Chen Y, Zhang J, Dai J, Feng X, Lu H, Zhou C (2010) Angiogenesis of renal cell carcinoma: perfusion CT findings. Abdom Imaging 35:622–628PubMedCrossRef Chen Y, Zhang J, Dai J, Feng X, Lu H, Zhou C (2010) Angiogenesis of renal cell carcinoma: perfusion CT findings. Abdom Imaging 35:622–628PubMedCrossRef
12.
Zurück zum Zitat Yang HF, Du Y, Ni JX et al (2010) Perfusion computed tomography evaluation of angiogenesis in liver cancer. Eur Radiol 20:1424–1430PubMedCrossRef Yang HF, Du Y, Ni JX et al (2010) Perfusion computed tomography evaluation of angiogenesis in liver cancer. Eur Radiol 20:1424–1430PubMedCrossRef
13.
Zurück zum Zitat d'Assignies G, Couvelard A, Bahrami S et al (2009) Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology 250:407–416PubMedCrossRef d'Assignies G, Couvelard A, Bahrami S et al (2009) Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology 250:407–416PubMedCrossRef
14.
Zurück zum Zitat Yao J, Yang ZG, Chen HJ, Chen TW, Huang J (2011) Gastric adenocarcinoma: can perfusion CT help to noninvasively evaluate tumor angiogenesis? Abdom Imaging 36:15–21PubMedCrossRef Yao J, Yang ZG, Chen HJ, Chen TW, Huang J (2011) Gastric adenocarcinoma: can perfusion CT help to noninvasively evaluate tumor angiogenesis? Abdom Imaging 36:15–21PubMedCrossRef
15.
Zurück zum Zitat Hansen S, Sorensen FB, Vach W et al (2003) Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients. Histopathology 44:428–436CrossRef Hansen S, Sorensen FB, Vach W et al (2003) Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients. Histopathology 44:428–436CrossRef
16.
Zurück zum Zitat Offersen BV, Borre M, Overgaard J (2003) Quantification of angiogenesis as a prognostic marker in human carcinomas: a critical evaluation of histopathological methods for estimation of vascular density. Eur J Cancer 39:881–890PubMedCrossRef Offersen BV, Borre M, Overgaard J (2003) Quantification of angiogenesis as a prognostic marker in human carcinomas: a critical evaluation of histopathological methods for estimation of vascular density. Eur J Cancer 39:881–890PubMedCrossRef
17.
Zurück zum Zitat Weidner N (1995) Intratumour microvessel density as a prognostic factor in cancer. Am J Pathol 147:9–19PubMed Weidner N (1995) Intratumour microvessel density as a prognostic factor in cancer. Am J Pathol 147:9–19PubMed
18.
Zurück zum Zitat Bettencourt M-C, Bauer JJ, Sesterhenn IA et al (1998) CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostatic cancer recurrence after radical prostatectomy. J Urol 160:459–465PubMedCrossRef Bettencourt M-C, Bauer JJ, Sesterhenn IA et al (1998) CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostatic cancer recurrence after radical prostatectomy. J Urol 160:459–465PubMedCrossRef
19.
Zurück zum Zitat Dales JP, Garcia S, Andrac L et al (2004) Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome. Int J Oncol 24:1197–1204PubMed Dales JP, Garcia S, Andrac L et al (2004) Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome. Int J Oncol 24:1197–1204PubMed
20.
Zurück zum Zitat Tanaka F, Otake Y, Yanagihara K et al (2001) Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and Anti-CD105 antibody. Clin Cancer Res 7:3410–15PubMed Tanaka F, Otake Y, Yanagihara K et al (2001) Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and Anti-CD105 antibody. Clin Cancer Res 7:3410–15PubMed
21.
Zurück zum Zitat Middleton J, Americh L, Gayon R et al (2005) A comparative study of endothelial cell markers expressed in chronically inflamed human tissues: ECA-79, Duffy antigen receptor for chemokines, von Willebrand factor, CD31, CD34, CD105 and CD146. J Pathol 206:260–268PubMedCrossRef Middleton J, Americh L, Gayon R et al (2005) A comparative study of endothelial cell markers expressed in chronically inflamed human tissues: ECA-79, Duffy antigen receptor for chemokines, von Willebrand factor, CD31, CD34, CD105 and CD146. J Pathol 206:260–268PubMedCrossRef
22.
Zurück zum Zitat Beliën JA, Somi S, de Jong JS et al (1999) Fully automated microvessel counting and hot spot selection by image processing of whole tumour sections in invasive breast cancer. J Clin Pathol 52:184–192PubMedCrossRef Beliën JA, Somi S, de Jong JS et al (1999) Fully automated microvessel counting and hot spot selection by image processing of whole tumour sections in invasive breast cancer. J Clin Pathol 52:184–192PubMedCrossRef
23.
Zurück zum Zitat Fox SB, Harris AL (2004) Histological quantitation of tumour angiogenesis. APMIS 112:413–430PubMedCrossRef Fox SB, Harris AL (2004) Histological quantitation of tumour angiogenesis. APMIS 112:413–430PubMedCrossRef
24.
Zurück zum Zitat Hansen S, Grabau DA, Sørensen FB et al (2000) The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients. Clin Cancer Res 6:139–146PubMed Hansen S, Grabau DA, Sørensen FB et al (2000) The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients. Clin Cancer Res 6:139–146PubMed
25.
Zurück zum Zitat Fox SB, Leek RD, Weekes MP et al (1995) Quantification and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count and computer image analysis. J Pathol 177:275–283PubMedCrossRef Fox SB, Leek RD, Weekes MP et al (1995) Quantification and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count and computer image analysis. J Pathol 177:275–283PubMedCrossRef
26.
Zurück zum Zitat Vermeulen PB, Gasparini G, Fox SB et al (2002) Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 38:1564–1579PubMedCrossRef Vermeulen PB, Gasparini G, Fox SB et al (2002) Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 38:1564–1579PubMedCrossRef
27.
Zurück zum Zitat Des Guetz G, Uzzan B, Nicolas P et al (2006) Microvessel density and VEGF expression are prognostic factors in colorectal cancer. meta-analysis of the literature. Br J Cancer 94:1823–1832PubMedCrossRef Des Guetz G, Uzzan B, Nicolas P et al (2006) Microvessel density and VEGF expression are prognostic factors in colorectal cancer. meta-analysis of the literature. Br J Cancer 94:1823–1832PubMedCrossRef
28.
Zurück zum Zitat Li ZP, Meng QF, Sun CH et al (2005) Tumor angiogenesis and dynamic CT in colorectal carcinoma: radiologic-pathologic correlation. World J Gastroenterol 11:1287–1291PubMed Li ZP, Meng QF, Sun CH et al (2005) Tumor angiogenesis and dynamic CT in colorectal carcinoma: radiologic-pathologic correlation. World J Gastroenterol 11:1287–1291PubMed
29.
Zurück zum Zitat Feng ST, Sun CH, Li ZP et al (2010) Evaluation of angiogenesis in colorectal carcinoma with multidetector-row CT multislice perfusion imaging. Eur J Radiol 75:191–196PubMedCrossRef Feng ST, Sun CH, Li ZP et al (2010) Evaluation of angiogenesis in colorectal carcinoma with multidetector-row CT multislice perfusion imaging. Eur J Radiol 75:191–196PubMedCrossRef
Metadaten
Titel
Assessment of the metabolic flow phenotype of primary colorectal cancer: correlations with microvessel density are influenced by the histological scoring method
verfasst von
Vicky Goh
Manuel Rodriguez-Justo
Alec Engledow
Manu Shastry
Raymondo Endozo
Jacqui Peck
Marie Meagher
Stuart A. Taylor
Steve Halligan
Ashley M. Groves
Publikationsdatum
01.08.2012
Verlag
Springer-Verlag
Erschienen in
European Radiology / Ausgabe 8/2012
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-012-2423-4

Weitere Artikel der Ausgabe 8/2012

European Radiology 8/2012 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.